USANA Health Sciences Inc
NYSE:USNA
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
34.48
54.45
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one USNA stock under the Base Case scenario is 42.6 USD. Compared to the current market price of 38.05 USD, USANA Health Sciences Inc is Undervalued by 11%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
USANA Health Sciences Inc
Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
Historical valuation for USNA cannot be conducted due to limitations such as insufficient data or other constraints.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
USANA Health Sciences Inc
Balance Sheet Decomposition
USANA Health Sciences Inc
Current Assets | 451.2m |
Cash & Short-Term Investments | 364.9m |
Other Current Assets | 86.3m |
Non-Current Assets | 220.1m |
PP&E | 98m |
Intangibles | 46.4m |
Other Non-Current Assets | 75.7m |
Current Liabilities | 114.8m |
Accounts Payable | 7m |
Other Current Liabilities | 107.7m |
Non-Current Liabilities | 23.4m |
Other Non-Current Liabilities | 23.4m |
Earnings Waterfall
USANA Health Sciences Inc
Revenue
|
862m
USD
|
Cost of Revenue
|
-165m
USD
|
Gross Profit
|
697m
USD
|
Operating Expenses
|
-614.7m
USD
|
Operating Income
|
82.3m
USD
|
Other Expenses
|
-28m
USD
|
Net Income
|
54.3m
USD
|
Free Cash Flow Analysis
USANA Health Sciences Inc
USD | |
Free Cash Flow | USD |
USNA Profitability Score
Profitability Due Diligence
USANA Health Sciences Inc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Score
USANA Health Sciences Inc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
USNA Solvency Score
Solvency Due Diligence
USANA Health Sciences Inc's solvency score is 91/100. The higher the solvency score, the more solvent the company is.
Score
USANA Health Sciences Inc's solvency score is 91/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
USNA Price Targets Summary
USANA Health Sciences Inc
According to Wall Street analysts, the average 1-year price target for USNA is 47.43 USD with a low forecast of 35.35 USD and a high forecast of 60.9 USD.
Dividends
Current shareholder yield for USNA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
USNA Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. The company is headquartered in Salt Lake City, Utah and currently employs 1,978 full-time employees. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, Foods, Personal Care and Skincare and All Other. Its USANA Nutritionals Optimizers product line consists of supplements designed to meet individual health and nutritional needs. Its Essentials/CellSentials product line includes vitamin and mineral supplements that provides a total body nutrition for every age group beginning with children 13 months of age. Its Foods product line includes meal replacement shakes, snack bars, and other related products that provides macro-nutrition. Its Personal Care and Skincare product line includes its science-based personal care products and Celavive, its skincare system. Its All Other product line includes materials and online tools that are designed to assist its associates in building their businesses and in marketing its products.
Contact
IPO
Employees
Officers
The intrinsic value of one USNA stock under the Base Case scenario is 42.6 USD.
Compared to the current market price of 38.05 USD, USANA Health Sciences Inc is Undervalued by 11%.